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Abstract
Neuromedin U, encoded by the NMU gene, is a hypothalamic neuropeptide that regulates both energy metabolism and
bone mass. The beta-2 adrenergic receptor, encoded by the ADRB2 gene, mediates several effects of catecholamine
hormones and neurotransmitters in bone. We investigated whether NMU single nucleotide polymorphisms (SNPs) and
haplotypes, as well as functional ADRB2 SNPs, are associated with bone stiffness in children from the IDEFICS cohort, also
evaluating whether NMU and ADRB2 interact to affect this trait. A sample of 2,274 subjects (52.5% boys, age 6.261.8 years)
from eight European countries, having data on calcaneus bone stiffness index (SI, mean of both feet) and genotyping (NMU
gene: rs6827359, rs12500837, rs9999653; ADRB2 gene: rs1042713, rs1042714), was studied. After false discovery rate
adjustment, SI was significantly associated with all NMU SNPs. rs6827359 CC homozygotes showed the strongest association
(recessive model, D=21.8, p= 0.006). Among the five retrieved haplotypes with frequencies higher than 1% (range 2.0–
43.9%), the CCT haplotype (frequency = 39.7%) was associated with lower SI values (dominant model, D=21.0, p= 0.04) as
compared to the most prevalent haplotype. A non-significant decrease in SI was observed in in ADRB2 rs1042713 GG
homozygotes, while subjects carrying SI-lowering genotypes at both SNPs (frequency = 8.4%) showed much lower SI than
non-carriers (D=23.9, p,0.0001; p for interaction = 0.025). The association was more evident in preschool girls, in whom SI
showed a curvilinear trend across ages. In subgroup analyses, rs9999653 CC NMU or both GG ADRB2 genotypes were
associated with either lower serum calcium or b-CrossLaps levels (p= 0.01). This study in European children shows, for the
first time in humans, a role for NMU gene through interaction with ADRB2 gene in bone strength regulation, more evident in
preschool girls.
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Introduction
Bone development is a key processes characterizing growth
during childhood and adolescence [1]. Understanding this process
is of crucial importance for planning strategies to prevent or treat
pediatric bone disorders, as well as osteoporosis later in life [2].
While it is well known that bone homeostasis is determined by the
cross-talk between osteoblasts and osteoclasts, the complexity of
the regulatory influences on these cells is continuously expanding
[3].
Neuromedin U (NMU) is a hypothalamic neuropeptide that
regulates various metabolic functions including energy homeostasis
and glycemic control [4]. Recently, Sato et al. [5] showed that
NMU double-null mice have increased bone mass, demonstrating
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also an interactive effect between single allele deletions of NMU
and beta-2-adrenergic receptor (ADRB2). Thus, NMU is involved also
in bone formation, acting as a central mediator of the effect of
leptin, lead by sympathetic nervous system (SNS), on osteoblast
ADRB2, which regulates cell proliferation [6,7]. No candidate
gene studies have been published on humans focusing on NMU
and bone health. Moreover, the polymorphisms most significantly
associated with bone health reported by genome-wide association
studies (GWAS) are located in DNA regions being far from NMU
[8]. However, GWAS mainly focus on SNPs with large effect and
did not investigate all polymorphisms in all genetic models, as well
as did not consider interactions among SNPs [9].
To provide more in depth knowledge on bone health in young
children, this study investigated a large sample of European
children of the IDEFICS study [10]. The project aimed at
identifying and preventing dietary- and lifestyle-related disorders
in children and infants, mainly focusing on overweight and obesity
as well as on bone health disorders, also in conjunction with
overweight [11], as it shares part of its risk factor profile. In the
present study we investigated the association between bone
stiffness and two candidate genes, NMU and ADRB2, focusing
on gene-gene interactions. Moreover, we investigated whether, in
subjects carrying risk alleles, a bone loss is more evident at specific
ages during childhood and whether the loss interests bone mass or
microarchitecture.
Methods
Ethics Statement
The study was conducted according to the standards of the
Declaration of Helsinki. All applicable institutional and govern-
mental regulations pertaining to the ethical use of human
volunteers were followed during this research. Approval by the
appropriate ethical committees was obtained by each of the eight
centers engaged in the fieldwork (Belgium: Ethics Committee,
University Hospital, Gent; Cyprus: Cyprus National Bioethics
Committee; Estonia: Tallinn Medical Research Ethics Committee;
Germany: Ethics Committee, University of Bremen; Hungary:
Ege´szse´gu¨gyi Tudoma´nyos Tana´cs, Pe´cs; Italy: Comitato Etico,
ASL Avellino; Spain: Comite´ E´tico de Investigacio´n, Clı´nica de
Arago´n - CEICA; Sweden: Regional Ethics Review Board,
University of Gothenburg). Both the children and their parents
gave their oral (children) and written (parents) informed consent
for examinations, collection of samples, subsequent analysis and
storage of personal data and collected samples.
Study Population
IDEFICS is a large European multi-center study on childhood
obesity [10,12]. A cohort of 16,224 children aged 2–9 years has
been recruited in a population-based survey between September
2007 and May 2008 (T0), in eight European countries (Belgium,
Cyprus, Estonia, Germany, Hungary, Italy, Spain and Sweden)
using standardized procedures. A community-oriented interven-
tion program for primary prevention of obesity was implemented
[13]. Children were allocated to either control or intervention
group and were followed up for two years (T1, 2009–2010).
DNA was extracted from a subgroup of 4,678 samples
randomly selected from the total study population, stratified by
country [14,15]. All children with complete data on age, sex,
parental questionnaire, height, weight, hip and waist circumfer-
ences, birthplace and language spoken at home as well as with
provided saliva samples were included in the present analysis.
Although no formal enquiry about ethnicity was made, two
questions in the parental questionnaire provided information
about ethnicity. ‘‘Place of birth of both parents’’ and ‘‘language
habitually spoken at home’’ were used to select only children of
European descent. DNA was successfully extracted in all cases,
however, after the exclusion of samples with improbable DNA
yields or not correctly genotyped, 4,641 children had at least one
SNP successfully genotyped in the NMU (n = 4529) or ADRB2
(n = 4566) gene. During the IDEFICS baseline survey, calcaneal
quantitative ultrasound sonometry (QUS) measurements were
performed in 7,447 children. The present analysis refers to the
2,267 children with genotypes and QUS data available at T0.
QUS measurements were performed also two years later, during
the follow-up, in 1,792 genotyped children.
Calcaneal Bone Stiffness
Calcaneal QUS measurements were performed using Lunar
Achilles Insight (GE Healthcare, Milwaukee, WI, USA) [16]. In
previous studies conducted on children, coefficient of variation was
1.9–3.5% [17–19]. Good values of short- and long-term interunit
precision were reported in a prospective multicenter study [20,21].
Calibration of the QUS devices has been performed daily during
the entire study period. Measurements were made according to
the standard procedure provided by the manufacturer. The real
time image of the calcaneus and the ROI parameter ensures that
the measurement is accurate and alerts the examiner to perform
the measure again when a child moved too much. An adapter was
used for children’s feet in order to get the proper position of the
calcaneus.
The device estimates calcaneal bone stiffness index (SI),
calculated from broadband ultrasound attenuation (BUA) and
speed of sound (SOS): SI = (0.676BUA)+(0.286SOS) - 420.
Precision ranged from 1.0 to 3.8% (CV) for BUA and from 0.19
to 0.30% (CV) for SOS [22]. The intermediate values BUA and
SOS to calculate SI were retained and registered in the database
only in few centers and are available only for 878 children (T1).
Both feet were measured once (100% of measures) and the mean
SI of both feet was calculated and used in the statistical analyses, as
well as for BUA and SOS when available.
Anthropometric Measures
The measurement of weight was carried out using an electronic
scale (Tanita BC 420 SMA, Tanita Europe GmbH, Sindelfingen,
Germany) to the nearest 0.1 kg with children wearing indoor
clothes, without shoes. Height was measured using a telescopic
height-measuring instrument (Seca 225 stadiometer, Birmingham,
UK) to the nearest 0.1 cm. The body mass index (BMI) was
calculated as weight (in kg) divided by height squared (in m).
Genotyping
Tagging SNPs of NMU gene were selected from the release 2.0
Phase II data of the HapMap Project (http://hapmap.ncbi.nlm.
nih.gov/) using the Tagger program of Haploview software (v4.1)
[23]. Selection criteria included r2#0.8 and a minor allele
frequency (MAF) $0.05 in Caucasians. NMU gene spans
56,156,162-56,197,222 bp (NCBI.36) on chromosome region
4q12. We selected a region that includes the third block
(56,187,256-56,193,006) containing eight SNPs. Of these, three
tag SNPs (rs6827359, rs12500837, rs9999653) located in intronic
regions were genotyped. Two missense coding SNPs in ADRB2
gene, rs1042713 (Arg16Gly) and rs1042714 (Gln27Glu), were
selected according to previous literature on obesity risk [24,25].
Saliva samples collected (Oragene DNA Self-Collection Kit,
OG-300/OG-250; DNA Genotek Inc., Kanata, Ontario, Canada)
from participating children were shipped to the central laboratory
at the University of Glasgow for DNA extraction [14].
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Variants of NMU gene were genotyped at Fondazione
‘‘Giovanni Paolo II’’ by a multiplexed end-point assay that detects
variants of a single nucleic acid sequence. The allelic discrimina-
tion was performed by 7500 Fast Real-Time System (Applied
Biosystems) using 96-well reaction plate with standard reagents
and standard protocols. Result analysis was made by SDS v1.4
software (Applied Biosystems). Variants of ADRB2 gene were
genotyped at the University of Glasgow using Taqman assays
(Applied Biosystems, Warrington, UK). Genotype calls were made
by the analysis software (StepOne v2.1; Applied Biosystems). The
genotyping success rate of the five variants examined was on
average 97.6%. A random 5% repeated selection of samples for
each SNP was genotyped again with 100% concordance.
Blood Measures
Children participating in the IDEFICS survey were asked to
participate, on voluntary basis, in blood drawing. Serum/plasma
samples were stored at 280uC [26]. Serum calcium was
determined by a standard photometric test (o-Cresolphtalein) with
a Roche Cobas Integra 800 (Roche, Mannheim, Germany).
Serum cross-linked collagen N-telopeptides (b-CrossLaps) and
vitamin D (25(OH)D) were measured with an electrochemilumi-
nescence immunoassay using a Roche Modular E170 analyzer
(Roche). Serum leptin was determined by radioimmunoassay
(Mediagnost GmbH, Reutlingen, Germany) [27].
Statistical Analysis
The distribution of each polymorphism was assessed for
deviation from Hardy-Weinberg equilibrium with chi-square test.
General linear model analysis was applied to test the associations
between SI and gene variants with SAS software (v9.2 for
Windows, Cary, NC: SAS Institute Inc. 2002–2008) adjusting for
age, sex, country and, only for T1 measurements, intervention
(control vs intervention region). For each SNP, codominant,
dominant and recessive models were tested. To select the best
genetic model, we choose the genotype showing the most
significant results after correction for multiple comparisons using
false discovery rate (FDR) assessment. The resulting nine p values
were imported in SAS and tested using PROC MULTTEST
(INPVALUES option), which converts them in FDR adjusted
values, to allow the use of standard significance cut off (p,0.05).
The Haplo.stats package (v1.4.4; http://cran.r-project.org/web/
packages/haplo.stats/index.html) was used to estimate the NMU
haplotype frequencies (haplo.em function) and to verify the
associations between haplotype and phenotype (haplo.glm func-
tion). The most prevalent haplotype was chosen as reference. Only
the haplotypes with frequencies greater than 1% were taken into
consideration for association analyses. Age, sex, country (T0) and
intervention (T1 analysis) were considered as covariates. Codom-
inant model was tested as main model, then dominant and
recessive models were also tested. To investigate if an association
between genotypes and SI is driven by bone mineral density rather
than by trabecular structure, supplementary analyses on BUA and
SOS parameters were performed in the subgroup of children with
available data on these parameters.
To verify the gene-gene interaction, an interaction analysis was
performed, testing the model with the two SNPs and their
interaction term in the general linear model analysis. Differences
in SI values were then verified between carriers and non-carriers
of the most associated genotypes of both NMU and ADRB2 genes.
To investigate the effect of age, sex and bone related
biomarkers, further analyses were performed. The association
between genotypes and SI were verified at different ages
(preschool and primary school children, less than or higher
than/equal to 6 years) [11] in both genders. Sex-specific SI trend
during the growth was analyzed for each genotype. A locally
weighted regression (LOESS) was used to test the assumption of a
linear vs. nonlinear relationship between SI and age. SI of each
child at T0 were plotted in a graph (PROC SGPLOT with
LOESS statement in SAS) using a scatterplot smoothing method
which automatically determines the optimal smoothing parameter
[28,29]. Adjustment for BMI or weight was performed using SI
residuals obtained after regression with BMI or weight as
covariates.
To give more insights in biological mechanisms, gene-environ-
mental interactions were tested using some bone related variables
as calcium (n = 605), 25-hydroxy vitamin D (n = 590), leptin
(n = 252) and beta-crosslaps (n = 592) levels in serum.
Results
Population Characteristics
Characteristics of the study population (N = 2,267, boys 52.4%)
are listed in table 1. All genotype groups were in Hardy-Weinberg
equilibrium and minor allele frequencies (MAF) resulted similar to
values reported in HapMap database for Caucasians (Table 2).
Five haplotypes were inferred with frequencies higher than 1%
(range 2.2%–43.3%; Table 3).
Associations between NMU and SI
Using FDR correction, four models resulted significantly
associated with SI among nine tested (p= 0.05; Table 4) at T0.
SI values were 1.5–2.5 points lower in homozygotes for the variant
allele C of both rs6827359 (raw p= 0.006) and rs12500837 (raw
p= 0.023), as well as in homozygotes for major allele C of
rs9999653 (both dominant and codominant model, raw p= 0.014
and 0.020, respectively), compared to carriers of the opposite
allele. The use of further covariates such as BMI or weight,
plausibly related to both genotypes and SI, did not change the
results. The phenotype variance explained by rs6827359 CC was
0.30%, while age plus sex explained 0.12% of variance.
The most prevalent haplotype was TTC (Table 3), then it was
used as referent haplotype. Subjects carrying the CCT haplotype
(containing the unfavorable allele C of both rs6827359 and
rs12500837) had lower SI than those carrying the most prevalent
one. This result obtained using standard additive model analysis
was statistically significant (p= 0.04, decreased value of 1 point for
each haplotype copy). Dominant and recessive models were also
tested, without significant results. Homozygotes for the haplotype
containing only one unfavorable allele in rs6827359 (CTT/CTT)
also showed lower SI values (22.2, p= 0.055, homozygosis
prevalence 6.2%; Table 4).
Data on QUS measurements at T1 did not reach the statistical
power needed to confirm the data, although SI values were
concordantly decreased in all three unfavorable genotypes (data
not shown).
NMU-ADRB2 Interaction
Significant association between ADRB2 genotypes and SI were
not found. However, gene-gene interaction analysis considering
both genotypes and their mathematical product revealed a
statistically significant effect also for their interaction term
(p= 0.025; table 4). Carriers of both the unfavorable genotypes
(rs6827359 CC of NMU and rs1042713 GG of ADRB2, n = 186)
were then compared with non-carriers, showing a larger difference
in SI than single rs6827359 (23.9, n = 1928, p,0.0001). The
presence of both variants explained 0.64% of the phenotype
variance. No significant effect was observed for SI values at T1.
Interaction between NMU and ADRB2 in Bone Health
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Sex-specific SI Trends during Growth
The interaction effect of categorical age (,6 or $6 years) and
sex on SI was nominally significant (p= 0.05). Therefore, the SI
differences between double opposite homozygotes in rs6827359
and rs1042713 polymorphisms were also tested in subgroups of
children stratified for age and/or sex. The differences remained
significant in both age classes and in both sexes. However, a
further stratified analysis combining sex per age subgroups showed
a large effect for younger girls (27.4 points for double risk
homozygotes, p= 0.005, p for interaction = 0.11), which was
statistically significant yet after FDR adjustment (p= 0.021, using
p values from the 4 subgroups of age class per sex), despite the
decreased sample size (Table 5). The use of BMI or weight as
covariates did not change the results.
SI trends during age among carriers and non-carriers of double
homozygosis conditions in the subgroups of girls and boys is
depicted in Figure 1. Despite the similar sample size, trends in
subgroups of boys (panel A) appear to be parallel, while girls (panel
B) carrying both risk genotypes showed a curvilinear trend, mainly
at preschool age. The trend did not become linear after
adjustment for BMI or weight.
Bone Related Parameters
BUA and SOS were available in a limited subgroup of subjects
collected at T1 (n = 865). As SI, SOS values were decreased in
carriers of all three unfavorable NMU genotypes, although non-
significantly. Moreover, a synergistic effect of NMU and ADRB2
genotypes was observed (p for interaction = 0.01), with carriers of
double unfavorable variants having a large decrease in SOS values
(210.7, p= 0.021) in comparison with non-carriers. The difference
resulted larger in children younger than 6 years (226.3, p= 0.008;
p for interaction = 0.017, n = 202). No significant effect was
observed for BUA values.
In a subsample ranging from 252 to 605 subjects where
biomarkers were measured, homozygosity for the C allele of NMU
rs9999653 was inversely associated with serum calcium levels,
while GG genotypes of both ADRB2 polymorphisms were
associated with lower levels of b-Crosslaps (p= 0.01 for all).
However, none of these parameters was associated with SI in this
subsample (data not shown).
Discussion
This is the first population study investigating the association
between NMU gene and bone health and its interaction with a
gene in the linked sympathetic nervous pathway involved in bone
Table 1. Population characteristics.
Variables T0 T1
(boys =52.4%) (boys =52.3%)
N Mean SD N Mean SD
Age [years] 2267 6.2 1.8 1792 8.3 1.8
Body Mass Index [kg/m2] 2267 16.3 2.2 1792 16.5 2.5
Weight [Kg] 2267 23.3 6.8 1792 24.0 7.2
Height [cm] 2267 118.5 13.0 1792 119.2 12.8
Stiffness index (mean of both feet) 2267 79.6 13.5 1792 82.9 13.5
Broadband ultrasound attenuation (BUA)
(mean of both feet) [dB/MHz] (T1)
NA NA NA 865 88.2 16.7
Speed of sound (SOS ) (mean of both feet) [m/sec] (T1) NA NA NA 865 1591.5 41.5
Calcium (serum) [mmol/l] 605 2.51 0.10 NA NA NA
25-hydroxy vitamin D (serum) [ng/ml] 590 18.26 6.80 NA NA NA
Leptin (serum) [ng/ml] 252 5.10 5.35 NA NA NA
Beta-crosslaps (serum) [ng/ml] 592 1.18 0.27 NA NA NA
NA=Not Available.
doi:10.1371/journal.pone.0070632.t001
Table 2. Allele frequencies and Hardy-Weinberg Equilibrium of NMU and ADRB2 gene polymorphisms (N = 2,267).
SNP Major:minor
Homozygous
major allele Heterozygous
Homozygous
minor allele p HWE MAF CEU
NMU rs6827359 T:C 26.9% 48.8% 24.3% 0.11 0.49 0.40
NMU rs12500837 T:C 57.3% 36.7% 6.0% 0.91 0.24 0.21
NMU rs9999653 C:T 21.5% 49.1% 29.4% 0.42 0.54 0.49
ADRB2 rs1042713 G:A 37.0% 47.6% 15.4% 0.90 0.39 0.32
ADRB2 rs1042714 C:G 37.5% 47.2% 15.3% 0.62 0.39 0.46
CEU:CEPH (Utah Residents with Northern and Western European Ancestry) from International Hapmap Project.
doi:10.1371/journal.pone.0070632.t002
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health regulation. Genetic variants of NMU gene are associated
with SI in European children of IDEFICS population, with allele
C of SNP rs6827359 showing the most significant decrease in SI.
Haplotype analysis confirmed the involvement of NMU gene and,
in particular, of SNP rs6827359, in bone health. Furthermore,
there was a significant interaction between NMU and ADRB2
gene, with double risk homozygous children showing a decrease of
3.9 point in SI with respect to double opposite homozygotes. The
effect appeared to be more evident in younger girls, in whom a
curvilinear SI trend during growth was observed. Subgroup
analyses showed that the effect on SI was mainly driven by the
effect on its component SOS and that the genotype-SI association
was not mediated by bone related biomarkers.
NMU is a hypothalamic neuropeptide, involved in the
regulation of various metabolic functions [4]. Recently, NMU
was suggested to be involved also in bone health determination
[5]. One of the main systems regulating bone formation involves
leptin that inhibits bone formation by binding to its receptors
located in hypothalamus and thereby activating the SNS. This
process requires the expression of ADRB2 in osteoblasts, which
mediates several effects of catecholamine hormones and neuro-
transmitters in bone [30]. The inhibition of bone formation
through a hypothalamic relay suggested that molecules affecting
energy metabolism in the hypothalamus, such as NMU, could also
modulate bone mass. Using transgenic mice, Sato et al. showed
that NMU acts as a modulator of leptin-SNS-ADRB2 regulation
of bone formation, through a central relay and via an unidentified
pathway. NMU-deficient mice had high bone mass due to an
increase in bone formation that was reversed by a natural agonist
for the NMU receptor. Furthermore, transgenic mice null for one
allele of both NMU and ADRB2 genes showed a more pronounced
increase in bone mass, suggesting an interaction between NMU
and ADRB2 [5–7]. We here demonstrated this phenomenon in
children, showing that different SI values are associated with
different NMU genotypes and with double homozygotes of both
NMU and ADRB2 risk genotypes. Thus, observations from in vitro
data and transgenic mouse models were confirmed in humans,
that NMU is involved in bone health and interacts with ADRB2
signal.
QUS is a radiation free, portable, cost-effective tool, measuring
properties of bone that contribute to mechanical bone strength by
sending sound waves; the more complex the bone structure, the
more sound waves will be absorbed [31]. Measuring SI with QUS
has value in assessing associations in children. In fact, over the last
decades, many studies used QUS to study bone strength in healthy
children at the calcaneus [17–19,32,33] even in preschool children
[12,34] and it was suggested to predict the risk of osteopenia or
fragility fracture [33,35]. Calcaneus is the most popular site for
QUS measurement since it consists for 90% of trabecular bone
and has a high turnover rate and therefore will show bone
metabolic changes first [1]. Moreover, using transaxial transmis-
sion, the QUS parameters are related to bone density and
structure and not to cortical thickness, which is an advantage when
examining children and adolescents, since cortical thickness varies
a lot during growth [36]. Finally, the safe and portable nature of
the method will allow designing feasible screening programs from
school to school, then calcaneus SI could became a useful marker
for public health interventions.
The SI is derived from the measured values BUA, which largely
reflects bone mineral density, and SOS, which reflects elasticity
and density due to trabecular connectivity [37]. Unfortunately,
BUA and SOS were available only at T1 and only for a subgroup
of children. Although the limited sample size, SOS showed a
strong association with double homozygosity of risk alleles. This
result suggests that NMU and ADRB2 are involved more in
microarchitecture formation than in mineral content accrual,
confirming the data from Sato et al. [5], showing a prevalent role
for NMU in osteoblast proliferation rather than in their function.
In fact, in NMU-null mice they observed higher osteoblast
numbers in the presence of a normal mineral apposition rate.
Despite the decreased sample size of subgroup analyses of age
and sex, in girls less than 6 years significant associations were
found between genotypes and SI, concordantly with the overall
sample. Analyzing trends across ages, in girls a curvilinear trend
was observed for carriers of both risk genotypes, while in boys SI
trends appeared to be linear and parallel. Since sample sizes of
boys and girls are similar, the reason of non-linearity should be
mainly attributed to the major dispersion of SI values observed in
pre-school girls, which suggest the involvement of other factors at
this age. Anyway, the stronger association observed in younger
girls could be determined by the NMU-SNS pathway and this
suggests to deeply investigating the sex-specific factors potentially
involved at earlier ages. These observations could be of relevance,
since bone peak at early ages has been associated with future
osteoporosis [2,38]. A link between the hypothalamic neuropep-
tide NMU and gonadotropin secretion is known [39], which
however takes places at later ages. Gender differences were also
Table 3. Haplotypes and haplotype frequency of the 3rd NMU
block (N= 2,267).
Haplotype
Haplotype
frequencya
rs6827359 rs12500837 rs9999653 Total
T T C 43.3%
C T T 24.4%
C C T 21.9%
T T T 8.2%
C C C 2.2%
aRare haplotypes with frequency lower than 1% were not considered (CTC, TCC
and TCT, accounting for 0.05%).
doi:10.1371/journal.pone.0070632.t003
Table 4. Differences in bone stiffness index (D SI) between
risk and non-risk genotype carriers at T0.
Gene SNP
Risk
genotype Frequency D SI Pa
NMU rs6827359 T/C CC 24.3% 21.8 0.006b
NMU rs12500837 T/C CC 6.0% 22.6 0.023b
NMU rs9999653 C/T CCc 21.5% 21.5 0.014b
NMU H3d CCT/x 39.7% 21.0 0.04
NMU H2d CTT/CTT 6.2% 22.2 0.055
ADRB2 rs1042713 G/A GGc 37.0% 20.9 0.09
ADRB2 rs1042714 C/G GG 15.3% 20.6 0.37
NMU*ADRB2 rs6827359*rs1042713 CC+GG 8.4% 23.9 ,0.0001
aAdjusted for age, sex and country.
bModel selected according to the highest association after FDR correction
(PROC MULTTEST in SAS software).
cHomozygotes for wild-type (instead of variant) allele were shown to
concordantly retain the genotypes with lower values.
dCarriers of Haplotype TTC as reference.
doi:10.1371/journal.pone.0070632.t004
Interaction between NMU and ADRB2 in Bone Health
PLOS ONE | www.plosone.org 5 August 2013 | Volume 8 | Issue 8 | e70632
reported in NMU-deficient mice [5], where the increase in bone
formation was however more prominent in male than in female
mice.
Finally, we investigated possible mechanisms underlying the
association between NMU/ADRB2 gene and bone stiffness, by
measuring biological markers related to bone metabolism in serum
samples of a children subgroup. Some associations were found
with calcium or b-CrossLaps levels, bone turnover markers,
however they were present for SNPs less associated with SI.
Furthermore, an association between SI and these biomarkers was
not found, due to limited statistical power in the subgroup of
genotyped subjects with biomarkers measured.
The study has some limitations.
Indeed, being the first study in humans suggesting an effect on
NMU on bone health, it needs confirmation. The GWAS
performed on bone health measured with different techniques
did not reveal any effect for SNPs near NMU region. However,
GWAS are focused on a relatively limited selection of polymor-
phisms which cannot be in linkage with all other known
polymorphism and report only highly significant associations, as
well as do not study neither all genetic model nor the interactive
effects among genotypes [9]. Furthermore, heritability of QUS
traits ranged from 0.42 to 0.57 [40], allowing further researches on
polymorphisms with minor effects or on plausible gene-gene
interactions.
The main strength of our study is a strong biological plausibility,
since our results reproduce those observed in mice [5]. Moreover,
it is performed on a large sample recruited in eight countries and it
is focused on children, in which environmental exposure time is
short and genetics should have more impact than expected.
In conclusion, our study in European children suggests an
involvement of NMU-SNS pathway in bone stiffness, mainly in
bone microarchitecture, more evident in preschool girls. The
identification of genetic markers in the NMU pathway could be
helpful in planning therapies for bone-loss disorders or metabolic
diseases using novel NMU receptors inhibitors or NMU analogs
[41], as well as in finding novel specific targets for preventive or
therapeutic interventions.
Table 5. Bone stiffness index values in children with different combination of NMU rs6827359 and ADRB2 rs1042713 alleles.
rs6827359* rs1042713 Overall Boys Girls
,6 years $6 years ,6 years $6 years
N Mean SD N Mean SD N Mean SD N Mean SD N Mean SD
00 (TT+AA) 1006 80.4 0.4 241 81.1 0.9 278 80.3 0.7 230 81.4 1.0 257 79.0 0.7
01 (TT+GG) 601 80.0 0.5 141 80.0 1.2 189 80.1 0.8 118 81.1 1.2 153 79.3 0.9
10 (CC+AA) 321 79.7 0.7 62 82.7 1.8 113 79.9 1.0 60 79.3 1.8 86 77.8 1.2
11 (CC+GG) 186 76.3 0.9 40 76.4 2.3 61 77.3 1.4 29 73.5 2.6 56 76.8 1.5
P for interaction 0.025 0.120 0.262 0.105 0.583
00+01+10 1928 80.1 0.3 444 81.1 0.7 579 80.2 0.5 408 80.9 0.7 496 78.9 0.5
11 (CC+GG) 186 76.3 0.9 40 76.4 2.3 61 77. 3 1.4 29 73.5 2.6 56 76.8 1.5
11 vs 10+01+00 Delta 23.9 24.7 22.9 27.4 22.1
P value 0.0001 0.045 0.051 0.005 0.189
Stiffness index values are least square means computed in a glm analysis using the variable with the four genotypes as independent variable. P for interaction was
computed for CC*GG. P value for the association with double homozygotes for risk alleles were reported (heterozygotes were excluded).
doi:10.1371/journal.pone.0070632.t005
Figure 1. Distribution of SI values at different ages, stratified for genotypes and sex. SI values and their 95% confidence intervals at
different ages for homozygotes of both NMU rs6827359 and ADRB2 rs1042713 risk alleles (CC+GG, dark grey) and homozygotes for non-risk alleles
(TT+AA, light gray) in subgroups of boys (panel A, n = 620, carriers of CC+GG=101) and girls (panel B, n = 572, carriers of CC+GG=85). Graph was
obtained using SAS software (PROC SGPLOT with LOESS statement, see text). Local regression method implies that statistical power decreases at
extreme x values (larger confidence intervals).
doi:10.1371/journal.pone.0070632.g001
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